UBS Group’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

UBS Group’s Portfolio HAAC Stock Details HAAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,560	Closed	-$96K	–	11870
2022 Q3	$96K	Buy	9,560 +699	+8%	+$6.95K	﹤0.01%	5750
2022 Q2	$88K	Sell	8,861 -249	-3%	-$2.46K	﹤0.01%	5529
2022 Q1	$89K	Sell	9,110 -5,264	-37%	-$51.6K	﹤0.01%	6007
2021 Q4	$141K	Buy	14,374 +7,849	+120%	+$76.9K	﹤0.01%	5983
2021 Q3	$64K	Sell	6,525 -1,999	-23%	-$19.6K	﹤0.01%	6146
2021 Q2	$85K	Buy	8,524 +1,627	+24%	+$16.6K	﹤0.01%	6010
2021 Q1	$70K	Buy	+6,897	New	+$81.7K	﹤0.01%	6242

Other funds holding HAAC

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS Group's HAAC Position: Q4 2022 in Review

UBS Group sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 9,560 shares — an estimated $96K sold.

UBS Group first reported a position in HAAC in Q1 2021 and held it in 7 quarters. The position peaked at $141K in Q4 2021. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

UBS Group reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 9,560 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $96K.
UBS Group first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
UBS Group's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $141K in Q4 2021.
1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.